次世代定序服务市场规模、份额、成长分析、按类型、按技术、按工作流程、按最终用途、按应用、按地区 - 行业预测，2025-2032 年

2023年全球次世代定序服务市场规模预计为84亿美元，从2024年的102.8亿美元成长到2032年的51.8亿美元，预计预测期间（2025-2032年）复合年增长率为22.4%。至十亿美元。

次世代定序(NGS)，也称为大规模并行定定序，透过实现快速、高通量 DNA定序正在为生物技术、医学诊断和病毒学等领域带来革命性的变化。与传统桑格方法相比，该技术显着减少了序列测定所需的时间，从而增强了临床和应用研究。 NGS 促进了关键的 DNA 预测序步骤并简化了样品製备和分析。随着临床实验室的应用不断增长，NGS 能够在药物基因组学中实现更快的疾病诊断和更有效的药物发现。透过识别用于早期检测的生物标记并实现个人化治疗策略，NGS 正在促进向精准医疗的转变，儘管是一个相对较新的市场，但分子生物学和遗传学已展现出变革性的影响。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

次世代定序服务市场规模：按类型

• 市场概况
• 人类基因组序列
• 单细胞定序
• 基于微生物基因组的序列分析
• 基因控制服务
  • 小RNA定序
  • 晶片序列
  • 其他基于基因调控的服务
• 动植物序列分析
• 其他定序服务

次世代定序服务市场规模：依技术划分

• 市场概况
• 合成定定序
• 离子半导体定序
• 奈米孔定序
• 单分子即时定序
• 其他技术

次世代定序服务市场规模：依工作流程划分

• 市场概况
• 前序
• 定序
• 资料分析

次世代定序服务市场规模：依最终用途分类

• 市场概况
• 大学及其他研究机构
• 医院/诊所
• 製药和生物技术公司
• 其他的

次世代定序服务市场规模：依应用分类

• 市场概况
• 诊断
• 肿瘤学
• 生殖健康
• 感染疾病
• 罕见遗传疾病
• 其他的
• 药物发现
• 生物标记发现
• 微生物遗传学农业动物研究
• 其他用途

次世代定序服务市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Illumina, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• BGI Genomics Co., Ltd.（China）
• Eurofins Scientific SE（Luxembourg）
• QIAGEN NV（Netherlands）
• Agilent Technologies, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Macrogen, Inc.（South Korea）
• Pacific Biosciences of California, Inc.（USA）
• Oxford Nanopore Technologies plc（UK）
• Novogene Co., Ltd.（China）
• Psomagen, Inc.（USA）
• 10x Genomics, Inc.（USA）
• Takara Bio Inc.（Japan）
• Zymo Research Corp.（USA）
• CD Genomics（USA）
• MedGenome Labs Pvt Ltd.（India）
• Fulgent Genetics, Inc.（USA）
• Personalis, Inc.（USA）

结论和建议

Global Next-Generation Sequencing Services Market size was valued at USD 8.4 billion in 2023 and is poised to grow from USD 10.28 billion in 2024 to USD 51.80 billion by 2032, growing at a CAGR of 22.4% during the forecast period (2025-2032).

Next-generation sequencing (NGS), also known as massively parallel sequencing, revolutionizes fields such as biotechnology, medical diagnostics, and virology by enabling rapid and high-throughput DNA sequencing. This technology significantly reduces the time required to sequence a complete human genome compared to traditional Sanger methods, enhancing clinical and applied research. NGS facilitates crucial DNA pre-sequencing steps, enabling streamlined sample preparation and analysis. Its growing application in clinical laboratories allows for quicker illness diagnosis and more efficient drug discovery in pharmacogenomics. By identifying biomarkers for early detection and enabling personalized treatment strategies, NGS catalyzes the shift towards precision medicine, demonstrating its transformative impact on molecular biology and genetics despite being relatively new to the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next-Generation Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next-Generation Sequencing Services Market Segmental Analysis

Global Next-Generation Sequencing Services Market is segmented by type, technology, workflow, end use, application and region. Based on type, the market is segmented into human genome sequencing, single cell sequencing, microbial genome-based sequencing, gene regulation services, animal & plant sequencing and other sequencing services. Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing and other technologies. Based on workflow, the market is segmented into pre-sequencing, sequencing and data analysis. Based on end use, the market is segmented into universities & other research entities, hospitals & clinics, pharma & biotech entities and others. Based on application, the market is segmented into diagnostics, oncology, reproductive health, infectious diseases, rare genetic disorders, others, drug discovery, biomarker discovery, microbial genetics, agriculture, and animal research and other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Next-Generation Sequencing Services Market

The global Next-Generation Sequencing (NGS) services market is experiencing significant growth, primarily driven by advancements in clinical diagnostics across various fields, including forensics, reproductive health, and personalized medicine. NGS has emerged as the industry benchmark in clinical laboratories for diagnosing genetic disorders due to its analytical precision, high throughput capabilities, and cost-effectiveness. As the technology becomes more affordable, NGS is increasingly accessible, facilitating the diagnosis and treatment of rare diseases through genomic approaches. Additionally, the expansion of library preparation options and the growing pool of trained personnel are further propelling market growth, while ongoing improvements in sequencing technologies pave the way for novel therapies targeting Mendelian disorders and cancer.

Restraints in the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing (NGS) Services market faces several restraints, primarily stemming from legal and ethical challenges associated with DNA sequencing. These concerns encompass issues such as identifiability, the release of research findings, potential stereotyping, the adequacy of consent, stigma, inclusion, and unequal benefits among different groups. Such ethical considerations significantly hinder market growth. Additionally, the challenges of establishing in-house high-throughput devices and interpreting the complex data generated by NGS platforms are critical factors that are anticipated to further impede market expansion in the upcoming years, creating a cautious atmosphere among stakeholders in the industry.

Market Trends of the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing (NGS) Services market is witnessing a significant shift towards advanced technologies such as third-generation sequencing, which bypass traditional clonal amplification and polymerase chain reaction (PCR) methodologies. Innovations in single-molecule sequencing and real-time sequencing offer advantages, including longer read lengths and simplified preparatory processes, which reduce the risk of PCR-related errors. Platforms like Single-Molecule Real-Time (SMRT) sequencing and the FRET Sequencing platform are gaining traction due to their high accuracy and efficiency, propelling the market forward. The growing demand for precision medicine, genomics research, and personalized healthcare is further driving the adoption of these next-gen solutions, positioning NGS services as a pivotal market trend.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Next-Generation Sequencing Services Market Size by Type & CAGR (2025-2032)

• Market Overview
• Human Genome Sequencing
• Single Cell Sequencing
• Microbial Genome-Based Sequencing
• Gene Regulation Services
  • Small RNA Sequencing
  • Chip Sequencing
  • Other Gene Regulation-Based Services
• Animal & Plant Sequencing
• Other Sequencing Services

Global Next-Generation Sequencing Services Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sequencing By Synthesis
• Ion Semiconductor Sequencing
• Nanopore Sequencing
• Single-Molecule Real-Time Sequencing
• Other Technologies

Global Next-Generation Sequencing Services Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Pre-Sequencing
• Sequencing
• Data Analysis

Global Next-Generation Sequencing Services Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Universities & Other Research Entities
• Hospitals & Clinics
• Pharma & Biotech Entities
• Others

Global Next-Generation Sequencing Services Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
• Oncology
• Reproductive Health
• Infectious Diseases
• Rare Genetic Disorders
• Others
• Drug Discovery
• Biomarker Discovery
• Microbial Genetics, Agriculture, And Animal Research
• Other Applications

Global Next-Generation Sequencing Services Market Size & CAGR (2025-2032)

• North America (Type, Technology, Workflow, End Use, Application)
  • US
  • Canada
• Europe (Type, Technology, Workflow, End Use, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Workflow, End Use, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Workflow, End Use, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Workflow, End Use, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedGenome Labs Pvt Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fulgent Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Personalis, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations